Form 483

G. Pohl-Boskamp GmbH & Co. KG Form 483, 2013-02-22

FDA issued a Form 483 to G. Pohl-Boskamp GmbH & Co. KG on 2013-02-22 with 2 public-safe observations.

483· Form 483 issuedHuman Drugs2 observations

G. Pohl-Boskamp GmbH & Co. KG · Hohenlockstedt, Germany · Issued February 22, 2013

Overview

  • 2 public-safe observations are available for this inspection.
  • 2 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

22 Feb 2013
21 CFR 211.160(a)

Following/documenting laboratory controls

Cited by Anita R Michael, Marianela Aponte Cruz

22 Feb 2013
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Anita R Michael, Marianela Aponte Cruz

Inspected site

GPG. Pohl-Boskamp GmbH & Co. KGHohenlockstedt, Germany

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.160(a)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 2 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere